CorTec ready for next phase with Brain Interchange System

As it prepares for the next stage of its groundbreaking device for the treatment of stroke, CorTec GmbH, a pioneering German medical technology company, is poised to make significant strides in the field of neurotechnology.

Breakthroughs following Neuralink's human brain chip implantation

As it gears up for the next phase of its stroke treatment device, CorTec is set to showcase its own advancements in the field. Proudly announcing the imminent human trials for its Brain Interchange System, CorTec reaffirms its dedication to innovation and enhancing therapeutic solutions.

Revolutionizing neuromodulation: Brain Interchange System set to transform treatment of neural network disorders

The Brain Interchange System represents a major leap forward in implanted neurotechnology. By continuously monitoring the brain´s state, it accurately assesses each patient’s individual therapeutic needs before precisely delivering optimal electrical stimulation therapy. The system is designed for the treatment of neural network disorders, such as epilepsy, schizophrenia, and Parkinson’s disease. The company invites journalists and members of the press to follow the progress of the Brain Interchange and witness the transformative impact it promises to have on the field of neuromodulation.

In addition, CorTec GmbH is offering exclusive interview opportunities with its Chief Technology Officer, Dr. Martin Schüttler, to provide in-depth insight into the technology behind the Brain Interchange System and the company’s vision for the future of neuromodulation.

Contact: Carolina Remke, CorTec GmbH
pr@cortec-neuro.com